Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder

Clinical trial NCT06086275 · COMPLETED

Trial details

NCT number: NCT06086275
Sponsor: Brigham and Women's Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Opioid Use Disorder

Start date: 2024-06-04
Primary completion: 2025-10-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.